Products and compositions

US11414660B2 · kind B2 · utility

Assignee

• Sapience Therapeutics, Inc. · DE

Inventors

• Judith Hauptmann · Berlin, DE
• Dmitry Samarsky · Berlin, DE
• Adrien Weingärtner · Berlin, DE
• Lucas Bethge · Potsdam, DE
• Christian Frauendorf · Berlin, DE
• Alison Gallafent · Berlin, DE

Key dates

• Filing date: Apr 5, 2018
• Grant date: Aug 16, 2022
• Expiry date: Apr 5, 2038

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C12N2320/51
• WIPO field: Biotechnology
• WIPO sector: Chemistry

Abstract

The present invention relates to products and compositions and their uses. In particular the invention relates to nucleic acid products that interfere with target gene expression or inhibit target gene expression and therapeutic uses of such products.